These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31168612)

  • 1. Oral Targeted Delivery by Nanoparticles Enhances Efficacy of an Hsp90 Inhibitor by Reducing Systemic Exposure in Murine Models of Colitis and Colitis-Associated Cancer.
    Yang M; Zhang F; Yang C; Wang L; Sung J; Garg P; Zhang M; Merlin D
    J Crohns Colitis; 2020 Jan; 14(1):130-141. PubMed ID: 31168612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Delivery of Nanoparticles Loaded With Ginger Active Compound, 6-Shogaol, Attenuates Ulcerative Colitis and Promotes Wound Healing in a Murine Model of Ulcerative Colitis.
    Zhang M; Xu C; Liu D; Han MK; Wang L; Merlin D
    J Crohns Colitis; 2018 Jan; 12(2):217-229. PubMed ID: 28961808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted delivery of the hydroxylase inhibitor DMOG provides enhanced efficacy with reduced systemic exposure in a murine model of colitis.
    Tambuwala MM; Manresa MC; Cummins EP; Aversa V; Coulter IS; Taylor CT
    J Control Release; 2015 Nov; 217():221-7. PubMed ID: 26385165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of Folic Acid-Targeted Temperature-Sensitive Magnetoliposomes and their Antitumor Effects In Vitro and In Vivo.
    Wang X; Yang R; Yuan C; An Y; Tang Q; Chen D
    Target Oncol; 2018 Aug; 13(4):481-494. PubMed ID: 29992403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate receptor targeted 17-allylamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric nanoparticles for breast cancer.
    Saxena V; Naguib Y; Hussain MD
    Colloids Surf B Biointerfaces; 2012 Jun; 94():274-80. PubMed ID: 22377218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orally Deliverable Nanotherapeutics for the Synergistic Treatment of Colitis-Associated Colorectal Cancer.
    Han W; Xie B; Li Y; Shi L; Wan J; Chen X; Wang H
    Theranostics; 2019; 9(24):7458-7473. PubMed ID: 31695780
    [No Abstract]   [Full Text] [Related]  

  • 7. KAG-308, a newly-identified EP4-selective agonist shows efficacy for treating ulcerative colitis and can bring about lower risk of colorectal carcinogenesis by oral administration.
    Watanabe Y; Murata T; Amakawa M; Miyake Y; Handa T; Konishi K; Matsumura Y; Tanaka T; Takeuchi K
    Eur J Pharmacol; 2015 May; 754():179-89. PubMed ID: 25704618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural-lipid nanoparticle-based therapeutic approach to deliver 6-shogaol and its metabolites M2 and M13 to the colon to treat ulcerative colitis.
    Yang C; Zhang M; Lama S; Wang L; Merlin D
    J Control Release; 2020 Jul; 323():293-310. PubMed ID: 32335157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image-guided photo-therapeutic nanoporphyrin synergized HSP90 inhibitor in patient-derived xenograft bladder cancer model.
    Long Q; Lin TY; Huang Y; Li X; Ma AH; Zhang H; Carney R; Airhart S; Lam KS; deVere White RW; Pan CX; Li Y
    Nanomedicine; 2018 Apr; 14(3):789-799. PubMed ID: 29317342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HSP90 inhibitor 17-AAG exhibits potent antitumor activity for pheochromocytoma in a xenograft model.
    Xu Y; Zhu Q; Chen D; Shen Z; Wang W; Ning G; Zhu Y
    Tumour Biol; 2015 Jul; 36(7):5103-8. PubMed ID: 25682284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice.
    Polytarchou C; Hommes DW; Palumbo T; Hatziapostolou M; Koutsioumpa M; Koukos G; van der Meulen-de Jong AE; Oikonomopoulos A; van Deen WK; Vorvis C; Serebrennikova OB; Birli E; Choi J; Chang L; Anton PA; Tsichlis PN; Pothoulakis C; Verspaget HW; Iliopoulos D
    Gastroenterology; 2015 Oct; 149(4):981-92.e11. PubMed ID: 26055138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine Model for Colitis-Associated Cancer of the Colon.
    Snider AJ; Bialkowska AB; Ghaleb AM; Yang VW; Obeid LM; Hannun YA
    Methods Mol Biol; 2016; 1438():245-54. PubMed ID: 27150094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid Nanoparticles Modified by Hyaluronic Acid Loading an HSP90 Inhibitor as a Novel Delivery System for Subcutaneous and Orthotopic Colon Cancer Therapy.
    Pan C; Zhang T; Li S; Xu Z; Pan B; Xu S; Jin S; Lu G; Yang S; Xue Z; Chen P; Shen X; Wang F; Xu C
    Int J Nanomedicine; 2021; 16():1743-1755. PubMed ID: 33688189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease.
    Shrestha N; Xu Y; Prévost JRC; McCartney F; Brayden D; Frédérick R; Beloqui A; Préat V
    Acta Biomater; 2022 Mar; 140():561-572. PubMed ID: 34923097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanocomposites-based targeted oral drug delivery systems with infliximab in a murine colitis model.
    Kim JM; Kim DH; Park HJ; Ma HW; Park IS; Son M; Ro SY; Hong S; Han HK; Lim SJ; Kim SW; Cheon JH
    J Nanobiotechnology; 2020 Sep; 18(1):133. PubMed ID: 32933548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage-Biomimetic Nanoparticles Ameliorate Ulcerative Colitis through Reducing Inflammatory Factors Expression.
    Li Z; Zhang X; Liu C; Peng Q; Wu Y; Wen Y; Zheng R; Yan Q; Ma J
    J Innate Immun; 2022; 14(4):380-392. PubMed ID: 34724662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease.
    Lautenschläger C; Schmidt C; Lehr CM; Fischer D; Stallmach A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):578-86. PubMed ID: 24084650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of inhibitory effects of 17-AAG nanoparticles and free 17-AAG on HSP90 gene expression in breast cancer.
    Ghalhar MG; Akbarzadeh A; Rahmati M; Mellatyar H; Dariushnejad H; Zarghami N; Barkhordari A
    Asian Pac J Cancer Prev; 2014; 15(17):7113-8. PubMed ID: 25227799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and in vitro evaluation of 17-allyamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric mixed micelles for glioblastoma multiforme.
    Saxena V; Hussain MD
    Colloids Surf B Biointerfaces; 2013 Dec; 112():350-5. PubMed ID: 24012704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid lipid nanoparticles as a novel formulation approach for tanespimycin (17-AAG) against leishmania infections: Preparation, characterization and macrophage uptake.
    Pires VC; Magalhães CP; Ferrante M; Rebouças JS; Nguewa P; Severino P; Barral A; Veras PST; Formiga FR
    Acta Trop; 2020 Nov; 211():105595. PubMed ID: 32585150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.